Literature DB >> 14500081

Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation.

Vassilios S Avlonitis1, Anna Krause, Luca Luzzi, Hazel Powell, Julie A Phillips, Paul A Corris, F Kate Gould, John H Dark.   

Abstract

OBJECTIVE: At the time of lung transplant, we routinely perform bronchoalveolar lavage (BAL) of the donor lungs on the recipient operating table immediately before implantation, for bacterial and fungal cultures. We sought to determine whether the results correlate with the outcome.
METHODS: We retrospectively analysed 115 consecutive cadaveric lung transplants (single lung: 42; bilateral lung: 63; heart-lung: 10) performed over 4 years.
RESULTS: Fifty-three (46%) grafts had positive BAL (bacteria: 33; fungus: 10; mixed: 10) and 62 (54%) were negative. Recipients with donor BAL culture positive for bacteria had lower mean oxygenation index in the first 6 h compared with those with negative bacterial culture (36.5+/-14.73 vs. 44.1+/-16.79 kPa) (P=0.019). They also had longer median intensive treatment unit stay (2.5 vs. 1.5 days) (P=0.035), and median time of mechanical ventilation (37.5 vs. 23.0 h) (P=0.008), as well as inferior 6-month, 1-year, 2-year and 4-year cumulative survival (79, 77, 74, 60% vs. 93, 92, 88, 79% respectively) (P=0.04). There was no difference in the above parameters between recipients with Gram-negative (n=18) and recipients with Gram-positive bacteria (n=19) in the donor BAL. Incidence of acute rejection within the first 2 weeks and time of onset of bronchiolitis obliterans syndrome (BOS) were similar in the bacteria-positive and bacteria-negative groups. Recipients with donor BAL positive for fungi alone had similar outcome with the negatives. There was no difference in the donor oxygenation index and age, recipient age, transplant type and ischaemic time between compared groups. There was a significant difference in the median length of donor mechanical ventilation between donors with Gram-positive and donors with Gram-negative bacteria in the BAL (24 vs. 48 h) (P=0.01), as well as between donors with fungi alone in the BAL and donors with negative BAL (67 vs. 48 h) (P=0.04).
CONCLUSIONS: Donor lungs with lower airways colonized with bacteria result in inferior recipient outcome. Bacterial colonization of the donor lower airways could therefore be used as a marker of donor lung injury, but evidence from a prospective study is necessary.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500081     DOI: 10.1016/s1010-7940(03)00454-8

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

Review 1.  Lung transplantation, ex-vivo reconditioning and regeneration: state of the art and perspectives.

Authors:  Lorenzo Rosso; Alberto Zanella; Ilaria Righi; Mario Barilani; Lorenza Lazzari; Eleonora Scotti; Francesca Gori; Paolo Mendogni
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Serum Amyloid A in lung transplantation.

Authors:  Lucia Vietri; Elena Bargagli; David Bennett; Antonella Fossi; Paolo Cameli; Laura Bergantini; Miriana d'Alessandro; Piero Paladini; Luca Luzzi; Francesco Gentili; Maria Antonietta Mazzei; Donatella Spina; Piersante Sestini; Paola Rottoli
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-15       Impact factor: 0.670

3.  Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation.

Authors:  Joseph L Bobadilla; Robert B Love; Ewa Jankowska-Gan; Qingyong Xu; Lynn D Haynes; Ruedi K Braun; Mary S Hayney; Alejandro Munoz del Rio; Keith Meyer; Daniel S Greenspan; Jose Torrealba; Kathleen M Heidler; Oscar W Cummings; Takekazu Iwata; David Brand; Robert Presson; William J Burlingham; David S Wilkes
Journal:  Am J Respir Crit Care Med       Date:  2008-01-03       Impact factor: 21.405

4.  Lipopolysaccharide pre-conditioning is protective in lung ischemia-reperfusion injury.

Authors:  Heather E Merry; Patrick S Wolf; Elizabeth Fitzsullivan; John C Keech; Michael S Mulligan
Journal:  J Heart Lung Transplant       Date:  2009-12-31       Impact factor: 10.247

Review 5.  Lung transplant infection.

Authors:  Sergio R Burguete; Diego J Maselli; Juan F Fernandez; Stephanie M Levine
Journal:  Respirology       Date:  2013-01       Impact factor: 6.424

Review 6.  Common infections in the lung transplant recipient.

Authors:  Karen D Sims; Emily A Blumberg
Journal:  Clin Chest Med       Date:  2011-06       Impact factor: 2.878

7.  Bacterial products in donor airways prevent the induction of lung transplant tolerance.

Authors:  Satona Tanaka; Jason M Gauthier; Yuriko Terada; Tsuyoshi Takahashi; Wenjun Li; Kohei Hashimoto; Ryuji Higashikubo; Ramsey R Hachem; Ankit Bharat; Jon H Ritter; Ruben G Nava; Varun Puri; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel
Journal:  Am J Transplant       Date:  2020-09-05       Impact factor: 8.086

8.  Late respiratory infection after lung transplantation.

Authors:  Sang Young Kim; Jung Ar Shin; Eun Na Cho; Min Kwang Byun; Hyung Jung Kim; Chul Min Ahn; Suk Jin Haam; Doo Yun Lee; Hyo Chae Paik; Yoon Soo Chang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-02-28

9.  The outcomes of 80 lung transplants in a single center from Saudi Arabia.

Authors:  Saeed Akram; Imran Yaqoob Nizami; Mohamed Hussein; Waleed Saleh; Mohammed Said Ismail; Khaled AlKattan; Muhammad Shaheryar Ahmed Rajput
Journal:  Ann Saudi Med       Date:  2019-08-05       Impact factor: 1.526

Review 10.  Life-threatening infection in transplant recipients.

Authors:  Daire T O'Shea; Atul Humar
Journal:  Crit Care Clin       Date:  2013-08-08       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.